Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 30,000 shares at $47.50 ($1.4M) on 2007-12-19, disclosed to the SEC on 2007-12-21.
Open-market sale of $1.4M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.50 | 2,000 | $95K | 6.7% |
| 2 | $47.51 | 2,900 | $138K | 9.7% |
| 3 | $47.52 | 4,800 | $228K | 16.0% |
| 4 | $47.53 | 300 | $14K | 1.0% |
| 5 | $47.00 | 1,069 | $50K | 3.5% |
| 6 | $47.26 | 2,000 |
| $95K |
| 6.6% |
| 7 | $47.30 | 4,000 | $189K | 13.3% |
| 8 | $47.31 | 2,129 | $101K | 7.1% |
| 9 | $47.32 | 1,931 | $91K | 6.4% |
| 10 | $47.38 | 800 | $38K | 2.7% |
| 11 | $48.00 | 71 | $3K | 0.2% |
| 12 | $48.03 | 2,000 | $96K | 6.7% |
| 13 | $48.06 | 3,000 | $144K | 10.1% |
| 14 | $48.06 | 1,000 | $48K | 3.4% |
| 15 | $48.09 | 2,000 | $96K | 6.7% |
| Total | $47.57 avg | 30,000 | $1.4M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |